First RNAi Insecticide Approved

This month, the EPA registered four products that include RNA interference technology intended to control corn rootworms.

Written byAggie Mika
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, TOM HLAVATY

This month, the US Environmental Protection Agency (EPA) approved the first plant-incorporated protectant (PIP) of its kind based on RNA interference (RNAi) technology, engineered to target western corn rootworms (Diabrotica virgifera virgifera), The Atlantic reports. According to a statement issued this month (June 15) by the EPA, four SmartStax Pro seed products with the RNAi-based PIP have been registered thus far.

PIPs are pesticides that plants are able to produce themselves, thanks to modifications to the plants’ genes, according to the EPA. While some crops already contain RNAi-technology for the purposes of fending off certain viruses, among other uses, this is the first insecticide to take advantage of this technology.

RNAi is a ubiquitous process across plant and animal cells, during which short RNA molecules hinder gene expression by homing in on and subsequently cleaving their complementary messenger RNA transcripts.

These SmartStax Pro corn seed products, The Atlantic reports, will incorporate DvSnf7 dsRNA. As prior research has demonstrated, this dsRNA, or ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA